News Conference News AHA 2023 POP-HT: Physician-Guided Self-Monitoring Improves BP After Hypertensive Pregnancy L.A. McKeown November 13, 2023
News Conference News AHA 2023 Intensive BP Reduction Lowers Dementia Risk in China Rural Hypertension Study Todd Neale November 12, 2023
News Conference News AHA 2023 Slash Dietary Sodium, Slash Blood Pressure: CARDIA-SSBP Michael O'Riordan November 12, 2023
News Conference News AHA 2022 Mindfulness Could Combat Uncontrolled Hypertension: MB-BP Yael L. Maxwell November 14, 2022
News Conference News AHA 2022 China Rural Intervention Still Reaping BP Control Wins at 3 Years L.A. McKeown November 09, 2022
News Conference News AHA 2022 SPYRAL HTN-ON MED Trial of Renal Denervation Misses Primary Endpoint Todd Neale November 09, 2022
News Conference News AHA 2022 Four Drugs, One Pill: QUARTET USA Supports New Strategy for BP-Lowering Caitlin E. Cox November 08, 2022
News Conference News AHA 2022 Big Drops in Blood Pressure With Baxdrostat: BrigHTN Phase II Study Michael O'Riordan November 07, 2022
News Conference News AHA 2021 Pharmacist-Led Intervention Slashes LDL and BP in 10,000 Patients Michael O'Riordan November 13, 2021
News Conference News AHA 2017 Long-Awaited Hypertension Guidelines Released at AHA Todd Neale November 13, 2017
News Conference News AHA 2013 Long-term Outcomes with Renal Denervation Show Sustained Benefit Yael L. Maxwell November 16, 2013
News Conference News AHA 2012 UMPIRE: Multidrug ‘Polypill’ Improves Adherence, BP, Cholesterol November 04, 2012
News Conference News AHA 2012 Early Study Shows Positive Clinical Results with Novel Renal Denervation Device Jason Kahn November 04, 2012